{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:45:19Z","timestamp":1792590319258,"version":"4.5.0"},"reference-count":60,"publisher":"MyJove Corporation","issue":"229","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoVE"],"DOI":"10.3791\/70093","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T23:01:20Z","timestamp":1773442880000},"source":"Crossref","is-referenced-by-count":0,"title":["Tanshinone-IIA Mediated Attenuation of Post-Infarction Myocardial Fibrosis via IL-33\/ST-2 Signaling Changes in Rat Epicardial Adipose Tissue"],"prefix":"10.3791","author":[{"given":"Kehan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuangyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2098","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","type":"journal-article","article-title":"Fourth universal definition of myocardial infarction","volume":"40","author":"Thygesen","year":"2018","unstructured":"Thygesen, K. et al. Fourth universal definition of myocardial infarction. Eur Heart J. 40 (3), 237-269 (2018).","journal-title":"Eur Heart J"},{"issue":"11","key":"ref2","first-page":"774","type":"journal-article","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge","volume":"38","author":"Heusch","year":"2016","unstructured":"Heusch, G., Gersh, B. J. The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge. Eur Heart J. 38 (11), 774-784 (2016).","journal-title":"Eur Heart J"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx085","type":"journal-article","article-title":"Improving outcome in acute coronary syndromes: ischaemic conditioning, antithrombosis and bleeding, and inflammasome antagonism","volume":"38","author":"L\u00fcscher","year":"2017","unstructured":"L\u00fcscher, T. F. Improving outcome in acute coronary syndromes: ischaemic conditioning, antithrombosis and bleeding, and inflammasome antagonism. Eur Heart J. 38 (11), 763-766 (2017).","journal-title":"Eur Heart J"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3892\/ijmm.2023.5312","type":"journal-article","article-title":"Tanshinone IIA confers protection against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1","volume":"52","author":"Hu","year":"2023","unstructured":"Hu, T. et al. Tanshinone IIA confers protection against myocardial ischemia\/reperfusion injury by inhibiting ferroptosis and apoptosis via VDAC1. Int J Mol Med. 52 (5), 109 (2023).","journal-title":"Int J Mol Med"},{"issue":"13","key":"ref5","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.7150\/thno.52843","type":"journal-article","article-title":"CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction","volume":"11","author":"Wang","year":"2021","unstructured":"Wang, Y. et al. CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction. Theranostics. 11 (13), 6315-6333 (2021).","journal-title":"Theranostics"},{"issue":"sup3","key":"ref6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1080\/21691401.2018.1508028","type":"journal-article","article-title":"Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-\u03baB pathway","volume":"46","author":"Mao","year":"2018","unstructured":"Mao, S., Wang, L., Chen, P., Lan, Y., Guo, R., Zhang, M. Nanoparticle-mediated delivery of Tanshinone IIA reduces adverse cardiac remodeling following myocardial infarctions in a mice model: role of NF-\u03baB pathway. Artif Cells Nanomed Biotechnol. 46 (sup3), 707-716 (2018).","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1221881","DOI":"10.3389\/fphar.2023.1221881","type":"journal-article","article-title":"Drugs for treating myocardial fibrosis","volume":"14","author":"Ren","year":"2023","unstructured":"Ren, Z., Zhang, Z., Ling, L., Liu, X., Wang, X. Drugs for treating myocardial fibrosis. Front Pharmacol. 14, 1221881 (2023).","journal-title":"Front Pharmacol"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1161\/CIRCULATIONAHA.121.058655","type":"journal-article","article-title":"Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction","volume":"147","author":"Tani","year":"2023","unstructured":"Tani, H. et al. Direct reprogramming improves cardiac function and reverses fibrosis in chronic myocardial infarction. Circulation. 147 (3), 223-238 (2023).","journal-title":"Circulation"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCRESAHA.123.322596","type":"journal-article","article-title":"TGF-\u03b21\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post\u2013myocardial infarction by inhibiting HDAC3","volume":"133","author":"Weng","year":"2023","unstructured":"Weng, L. et al. TGF-\u03b21\/SMAD3 regulates programmed cell death 5 that suppresses cardiac fibrosis post\u2013myocardial infarction by inhibiting HDAC3. Circ Res. 133 (3), 237-251 (2023).","journal-title":"Circ Res"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.7150\/thno.78736","type":"journal-article","article-title":"Hypoxia induces M2 macrophages to express VSIG4 and mediate cardiac fibrosis after myocardial infarction","volume":"13","author":"Wang","year":"2023","unstructured":"Wang, Y. et al. Hypoxia induces M2 macrophages to express VSIG4 and mediate cardiac fibrosis after myocardial infarction. Theranostics. 13 (7), 2192-2209 (2023).","journal-title":"Theranostics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"117012","DOI":"10.1016\/j.biopha.2024.117012","type":"journal-article","article-title":"Caffeic acid mitigates myocardial fibrosis and improves heart function in post-myocardial infarction by inhibiting transforming growth factor-\u03b2 receptor 1 signaling pathways","volume":"177","author":"Jiang","year":"2024","unstructured":"Jiang, W. et al. Caffeic acid mitigates myocardial fibrosis and improves heart function in post-myocardial infarction by inhibiting transforming growth factor-\u03b2 receptor 1 signaling pathways. Biomed Pharmacother. 177, 117012 (2024).","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/molecules21010051","type":"journal-article","article-title":"Chemical analysis of the herbal medicine Salviae miltiorrhizae radix et rhizoma (danshen)","volume":"21","author":"Pang","year":"2016","unstructured":"Pang, H., Wu, L., Tang, Y., Zhou, G., Qu, C., Duan, J. Chemical analysis of the herbal medicine Salviae miltiorrhizae radix et rhizoma (danshen). Molecules. 21 (1), 51 (2016).","journal-title":"Molecules"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"115501","DOI":"10.1016\/j.biopha.2023.115501","type":"journal-article","article-title":"Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2","volume":"167","author":"Ma","year":"2023","unstructured":"Ma, X., Zhang, L., Gao, F., Jia, W., Li, C. Salvia miltiorrhiza and Tanshinone IIA reduce endothelial inflammation and atherosclerotic plaque formation through inhibiting COX-2. Biomed Pharmacother. 167, 115501 (2023).","journal-title":"Biomed Pharmacother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"105364","DOI":"10.1016\/j.phrs.2020.105364","type":"journal-article","article-title":"Prospective therapeutic potential of Tanshinone IIA: An updated overview","volume":"164","author":"Ansari","year":"2021","unstructured":"Ansari, M. A. et al. Prospective therapeutic potential of Tanshinone IIA: An updated overview. Pharmacol Res. 164, 105364 (2021).","journal-title":"Pharmacol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"111404","DOI":"10.1016\/j.biopha.2021.111404","type":"journal-article","article-title":"A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment","volume":"137","author":"Bi","year":"2021","unstructured":"Bi, Z., Wang, Y., Zhang, W. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment. Biomed Pharmacother. 137, 111404 (2021).","journal-title":"Biomed Pharmacother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1252942","DOI":"10.3389\/fcell.2023.1252942","type":"journal-article","article-title":"Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4\/NF-\u03baB p65 pathway after acute myocardial infarction","volume":"11","author":"Chai","year":"2023","unstructured":"Chai, R. et al. Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4\/NF-\u03baB p65 pathway after acute myocardial infarction. Front Cell Dev Biol. 11, 1252942 (2023).","journal-title":"Front Cell Dev Biol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00850","type":"journal-article","article-title":"Tanshinone IIA exerts anti-inflammatory and immune-regulating effects on vulnerable atherosclerotic plaque partially via the T","volume":"10","author":"Chen","year":"2019","unstructured":"Chen, Z. Tanshinone IIA exerts anti-inflammatory and immune-regulating effects on vulnerable atherosclerotic plaque partially via the T. Front Pharmacol. 10 (2019).","journal-title":"Front Pharmacol"},{"issue":"7","key":"ref18","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/biom13071029","type":"journal-article","article-title":"Tanshinone IIA and cryptotanshinone counteract inflammation by regulating gene and miRNA expression in human SGBS adipocytes","volume":"13","author":"Carpi","year":"2023","unstructured":"Carpi, S. et al. Tanshinone IIA and cryptotanshinone counteract inflammation by regulating gene and miRNA expression in human SGBS adipocytes. Biomolecules. 13 (7), 1029 (2023).","journal-title":"Biomolecules"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/cells11060991","type":"journal-article","article-title":"Browning epicardial adipose tissue: Friend or Foe","volume":"11","author":"Doukbi","year":"2022","unstructured":"Doukbi, E. et al. Browning epicardial adipose tissue: Friend or Foe? Cells. 11 (6), 991 (2022).","journal-title":"Cells"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-022-00679-9","type":"journal-article","article-title":"Epicardial adipose tissue in contemporary cardiology","volume":"19","author":"Iacobellis","year":"2022","unstructured":"Iacobellis, G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 19 (9), 593-606 (2022).","journal-title":"Nat Rev Cardiol"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.tem.2011.07.003","type":"journal-article","article-title":"Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features","volume":"22","author":"Iacobellis","year":"2011","unstructured":"Iacobellis, G., Bianco, A.C. Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab. 22 (11), 450-457 (2011).","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrendo.2015.58","type":"journal-article","article-title":"Local and systemic effects of the multifaceted epicardial adipose tissue depot","volume":"11","author":"Iacobellis","year":"2015","unstructured":"Iacobellis, G. Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat Rev Endocrinol. 11 (6), 363-371 (2015).","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1467-789X.2006.00293.x","type":"journal-article","article-title":"Epicardial fat: properties, function, and relationship to obesity","volume":"8","author":"Rabkin","year":"2007","unstructured":"Rabkin, S. W. Epicardial fat: properties, function, and relationship to obesity. Obes Rev. 8 (3), 253-261 (2007).","journal-title":"Obes Rev"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ahj.2007.03.019","type":"journal-article","article-title":"Human epicardial adipose tissue: A review","volume":"153","author":"Sacks","year":"2007","unstructured":"Sacks, H. S., Fain, J. N. Human epicardial adipose tissue: A review. Am Heart J. 153 (6), 907-917 (2007).","journal-title":"Am Heart J"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12933-018-0679-y","type":"journal-article","article-title":"Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction","volume":"17","author":"Gruzdeva","year":"2018","unstructured":"Gruzdeva, O. et al. Relationships between epicardial adipose tissue thickness and adipo-fibrokine indicator profiles post-myocardial infarction. Cardiovasc Diabetol. 17 (1), 40 (2018).","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1089\/met.2008.0056","type":"journal-article","article-title":"Fatty acid composition of epicardial and subcutaneous human adipose tissue","volume":"7","author":"Pezeshkian","year":"2009","unstructured":"Pezeshkian, M. et al. Fatty acid composition of epicardial and subcutaneous human adipose tissue. Metab Syndr Relat Disord. 7 (2), 125-132 (2009).","journal-title":"Metab Syndr Relat Disord"},{"issue":"10","key":"ref27","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jacc.2020.07.017","type":"journal-article","article-title":"Epicardial adipose tissue accumulation confers atrial conduction abnormality","volume":"76","author":"Nalliah","year":"2020","unstructured":"Nalliah, C. J. et al. Epicardial adipose tissue accumulation confers atrial conduction abnormality. J Am Coll Cardiol. 76 (10), 1197-1211 (2020).","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"ref28","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","type":"journal-article","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","author":"Packer","year":"2018","unstructured":"Packer, M. Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol. 71 (20), 2360-2372 (2018).","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"ref29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","type":"journal-article","article-title":"Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines","volume":"36","author":"Venteclef","year":"2015","unstructured":"Venteclef, N. et al. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. Eur Heart J. 36 (13), 795-805 (2015).","journal-title":"Eur Heart J"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jacc.2023.05.031","type":"journal-article","article-title":"Role of human epicardial adipose tissue\u2013derived miR-92a-3p in myocardial redox state","volume":"82","author":"Carena","year":"2023","unstructured":"Carena, M. C. et al. Role of human epicardial adipose tissue\u2013derived miR-92a-3p in myocardial redox state. J Am Coll Cardiol. 82 (4), 317-332 (2023).","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","type":"journal-article","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","unstructured":"Liew, F. Y., Girard, J. P., Turnquist, H. R. Interleukin-33 in health and disease. Nat Rev Immunol. 16 (11), 676-689 (2016).","journal-title":"Nat Rev Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cca.2020.04.011","type":"journal-article","article-title":"Soluble ST2: A complex and diverse role in several diseases","volume":"507","author":"Homsak","year":"2020","unstructured":"Homsak, E., Gruson, D. Soluble ST2: A complex and diverse role in several diseases. Clin Chim Acta. 507, 75-87 (2020).","journal-title":"Clin Chim Acta"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2009.08.047","type":"journal-article","article-title":"Serum soluble ST2","volume":"55","author":"Weir","year":"2010","unstructured":"Weir, R. A. P. et al. Serum soluble ST2. J Am College Cardiol. 55 (3), 243-250 (2010).","journal-title":"J Am College Cardiol"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"e024417","DOI":"10.1161\/JAHA.121.024417","type":"journal-article","article-title":"Soluble ST2 is a sensitive and specific biomarker for fulminant myocarditis","volume":"11","author":"Wang","year":"2022","unstructured":"Wang, J. et al. Soluble ST2 is a sensitive and specific biomarker for fulminant myocarditis. J Am Heart Assoc. 11 (7), e024417 (2022).","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"ref35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1146\/annurev-immunol-101320-124243","type":"journal-article","article-title":"Emerging functions of IL-33 in homeostasis and immunity","volume":"40","author":"Dwyer","year":"2022","unstructured":"Dwyer, G. K., D\u2019Cruz, L. M., Turnquist, H. R. Emerging functions of IL-33 in homeostasis and immunity. Annu Rev Immunol. 40 (1), 15-43 (2022).","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","type":"journal-article","article-title":"Interleukin-33 in tissue homeostasis, injury, and inflammation","volume":"42","author":"Molofsky","year":"2015","unstructured":"Molofsky, A. B., Savage, A. K., Locksley, R. M. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity. 42 (6), 1005-1019 (2015).","journal-title":"Immunity"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI30634","type":"journal-article","article-title":"IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system","volume":"117","author":"Sanada","year":"2007","unstructured":"Sanada, S., Hakuno, D., Higgins, L. J., Schreiter, E. R., McKenzie, A. N. J., Lee, R. T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 117 (6), 1538-1549 (2007).","journal-title":"J Clin Invest"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cytogfr.2023.12.001","type":"journal-article","article-title":"Interleukin-33\/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases","volume":"76","author":"He","year":"2024","unstructured":"He, P. et al. Interleukin-33\/serum stimulation-2 pathway: Regulatory mechanisms and emerging implications in immune and inflammatory diseases. Cytokine Growth Factor Rev. 76, 112-126 (2024).","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","type":"journal-article","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","unstructured":"Saraiva, M., O\u2019Garra, A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 10 (3), 170-181 (2010).","journal-title":"Nat Rev Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"155891","DOI":"10.1016\/j.cyto.2022.155891","type":"journal-article","article-title":"Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine","volume":"156","author":"Cayrol","year":"2022","unstructured":"Cayrol, C., Girard, J. P. Interleukin-33 (IL-33): A critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine. Cytokine. 156, 155891 (2022).","journal-title":"Cytokine"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41577-022-00792-3","type":"journal-article","article-title":"Death by TNF: a road to inflammation","volume":"23","author":"Van Loo","year":"2023","unstructured":"Van Loo, G., Bertrand, M. J. M. Death by TNF: a road to inflammation. Nat Rev Immunol. 23 (5), 289-303 (2023).","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2009.04.081","type":"journal-article","article-title":"IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes","volume":"384","author":"Wood","year":"2009","unstructured":"Wood, I. S., Wang, B., Trayhurn, P. IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem Biophys Res Commun. 384 (1), 105-109 (2009).","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1161\/CIRCRESAHA.110.218867","type":"journal-article","article-title":"Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice","volume":"107","author":"Miller","year":"2010","unstructured":"Miller, A. M. et al. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circulation Research. 107 (5), 650-658 (2010).","journal-title":"Circulation Research"},{"key":"ref44","first-page":"595","type":"journal-article","article-title":"Tanshinone IIA in the treatment of myocardial fibrosis in animals: a systematic review","volume":"29","author":"Zhang","year":"2018","unstructured":"Zhang, L. et al. Tanshinone IIA in the treatment of myocardial fibrosis in animals: a systematic review. Tradit Chin Drug Res Clin Pharmacol. 29, 595-602(2018).","journal-title":"Tradit Chin Drug Res Clin Pharmacol"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.phymed.2010.06.002","type":"journal-article","article-title":"Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension","volume":"18","author":"Fang","year":"2010","unstructured":"Fang, J. et al. Tanshinone II-A attenuates cardiac fibrosis and modulates collagen metabolism in rats with renovascular hypertension. Phytomedicine. 18 (1), 58-64 (2010).","journal-title":"Phytomedicine"},{"issue":"20","key":"ref46","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCULATIONAHA.119.040631","type":"journal-article","article-title":"Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury","volume":"140","author":"DeFilippis","year":"2019","unstructured":"DeFilippis, A. P. et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation. 140 (20), 1661-1678 (2019).","journal-title":"Circulation"},{"issue":"10","key":"ref47","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/cvr\/cvaa331","type":"journal-article","article-title":"Cardiac troponin and defining myocardial infarction","volume":"117","author":"Kaier","year":"2021","unstructured":"Kaier, T. E., Alaour, B., Marber, M. Cardiac troponin and defining myocardial infarction. Cardiovasc Res. 117 (10), 2203-2215 (2021).","journal-title":"Cardiovasc Res"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.phymed.2014.06.013","type":"journal-article","article-title":"Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza","volume":"21","author":"Hu","year":"2014","unstructured":"Hu, T. et al. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine. 21 (11), 1264-1272 (2014).","journal-title":"Phytomedicine"},{"issue":"32","key":"ref49","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1039\/C8TB01136B","type":"journal-article","article-title":"Codelivery of doxorubicin and sodium tanshinone IIA sulfonate using multi-compartmentalized vesosomes to enhance synergism and prevent doxorubicin-induced cardiomyocyte apoptosis","volume":"6","author":"Zhang","year":"2018","unstructured":"Zhang, X., Zong, W., Cheng, W., Han, X. Codelivery of doxorubicin and sodium tanshinone IIA sulfonate using multi-compartmentalized vesosomes to enhance synergism and prevent doxorubicin-induced cardiomyocyte apoptosis. J Mater Chem B. 6 (32), 5243-5247 (2018).","journal-title":"J Mater Chem B"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2155-8256(19)30011-0","type":"journal-article","article-title":"The growth and performance of nursing programs by ownership status","volume":"9","author":"Pittman","year":"2019","unstructured":"Pittman, P., Bass, E., Han, X., Kurtzman, E. The growth and performance of nursing programs by ownership status. J Nurs Regul. 9 (4), 5-21 (2019).","journal-title":"J Nurs Regul"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/ehjci\/jez182","type":"journal-article","article-title":"Relationship between epicardial adipose tissue and coronary vascular function in patients with suspected coronary artery disease and normal myocardial perfusion imaging","volume":"20","author":"Nappi","year":"2019","unstructured":"Nappi, C. et al. Relationship between epicardial adipose tissue and coronary vascular function in patients with suspected coronary artery disease and normal myocardial perfusion imaging. Eur Heart J Cardiovasc Imaging. 20 (12), 1379-1387 (2019).","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"ref52","first-page":"251","type":"journal-article","article-title":"Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease","volume":"29","author":"Iacobellis","year":"2005","unstructured":"Iacobellis, G. et al. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 29, 251-255 (2005).","journal-title":"Cytokine"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/s-0029-1231081","type":"journal-article","article-title":"Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease","volume":"41","author":"Iacobellis","year":"2009","unstructured":"Iacobellis, G. et al. Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Horm Metab Res. 41 (12), 855-860 (2009).","journal-title":"Horm Metab Res"},{"issue":"23","key":"ref54","doi-asserted-by":"crossref","first-page":"5989","DOI":"10.3390\/ijms20235989","type":"journal-article","article-title":"Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk","volume":"20","author":"Villasante Fricke","year":"2019","unstructured":"Villasante Fricke, A. C., Iacobellis, G. Epicardial adipose tissue: clinical biomarker of cardio-metabolic risk. Int J Mol Sci. 20 (23), 5989 (2019).","journal-title":"Int J Mol Sci"},{"issue":"20","key":"ref55","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.0000099542.57313.C5","type":"journal-article","article-title":"Human epicardial adipose tissue is a source of inflammatory mediators","volume":"108","author":"Mazurek","year":"2003","unstructured":"Mazurek, T. et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 108 (20), 2460-2466 (2003).","journal-title":"Circulation"},{"issue":"9","key":"ref56","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-021-04111-x","type":"journal-article","article-title":"Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation","volume":"12","author":"Hao","year":"2021","unstructured":"Hao, S. et al. Secretory products from epicardial adipose tissue induce adverse myocardial remodeling after myocardial infarction by promoting reactive oxygen species accumulation. Cell Death Dis. 12 (9), 848 (2021).","journal-title":"Cell Death Dis"},{"issue":"1","key":"ref57","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/cvr\/cvv208","type":"journal-article","article-title":"Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location","volume":"108","author":"Gaborit","year":"2015","unstructured":"Gaborit, B. et al. Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location. Cardiovasc Res. 108 (1), 62-73 (2015).","journal-title":"Cardiovasc Res"},{"issue":"3","key":"ref58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s00059-017-4555-4","type":"journal-article","article-title":"Removal of epicardial adipose tissue after myocardial infarction improves cardiac function","volume":"43","author":"Chang","year":"2018","unstructured":"Chang, H. X., Zhao, X. J., Zhu, Q. L., Hou, Q., Li, Y. Removal of epicardial adipose tissue after myocardial infarction improves cardiac function. Herz. 43 (3), 258-264 (2018).","journal-title":"Herz"},{"issue":"6","key":"ref59","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.jaci.2014.05.011","type":"journal-article","article-title":"IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice","volume":"134","author":"Li","year":"2014","unstructured":"Li, D. et al. IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol. 134 (6), 1422-1432 (2014).","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"H985","DOI":"10.1152\/ajpheart.00720.2005","type":"journal-article","article-title":"Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo","volume":"290","author":"Ha","year":"2006","unstructured":"Ha, T. et al. Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo. Am J Physiol Heart Circ Physiol. 290 (3), H985-H994 (2006).","journal-title":"Am J Physiol Heart Circ Physiol"}],"container-title":["Journal of Visualized Experiments"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/app.jove.com\/t\/70093\/tanshinone-iia-mediated-attenuation-post-infarction-myocardial","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:14:59Z","timestamp":1792588499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jove.com\/t\/70093\/tanshinone-iia-mediated-attenuation-post-infarction-myocardial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":60,"journal-issue":{"issue":"229","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.3791\/70093","relation":{},"ISSN":["1940-087X"],"issn-type":[{"value":"1940-087X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]}}}